Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in veterinary medicine
3.2.1.2 Increasing prevalence of renal diseases in companion animals
3.2.1.3 Growing awareness among pet owners and veterinarians
3.2.1.4 Rising demand for renoprotective diets
3.2.2 Industry pitfalls & challenges
3.2.2.1 Off-label use of drugs in veterinary treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Million)
5.1 Key trends
5.2 Treatment
5.2.1 Drugs
5.2.1.1 By drug type
5.2.1.1.1 NSAIDs
5.2.1.1.2 Antibiotics
5.2.1.1.3 Cystine-binding agents
5.2.1.1.4 Diuretics
5.2.1.1.5 Other drugs
5.2.1.2 By route of administration
5.2.1.2.1 Oral
5.2.1.2.1.1 Injectable
5.2.1.3 By distribution channel
5.2.1.3.1 Pharmacies
5.2.1.3.2 Pet specialty stores
5.2.1.3.3 E-commerce
5.2.1.3.4 Other distribution channels
5.2.2 Food supplements
5.3 Diagnosis
5.3.1 Test kits & consumables
5.3.2 Instruments
Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 – 2032 ($ Million)
6.1 Key trends
6.2 Bovine
6.3 Canine
6.4 Feline
6.5 Equine
6.6 Other animal types
Chapter 7 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Million)
7.1 Key trends
7.2 Renal failure
7.3 Chronic kidney disease (CKD)
7.4 Renal cystitis
7.5 Kidney stones
7.6 Nephritis
7.7 Other indications
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Boehringer Ingelheim International GmbH
9.2 Dechra Pharmaceuticals
9.3 Elanco Animal Health Incorporated
9.4 General Mills Inc.
9.5 Hill's Pet Nutrition, Inc.
9.6 IDEXX Laboratories, Inc.
9.7 The J.M. Smucker Company
9.8 Mars Incorporated
9.9 Merck & Co., Inc.
9.10 Nestle Purina
9.11 Phibro Animal Health Corporation
9.12 Zoetis Inc.
